Menu
GeneBe

rs116306908

Positions:

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003383.5(VLDLR):ā€‹c.982A>Gā€‹(p.Ser328Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000408 in 1,614,184 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S328S) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.0022 ( 1 hom., cov: 32)
Exomes š‘“: 0.00022 ( 2 hom. )

Consequence

VLDLR
NM_003383.5 missense

Scores

1
11
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 6.20
Variant links:
Genes affected
VLDLR (HGNC:12698): (very low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene. [provided by RefSeq, Aug 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018847704).
BP6
Variant 9-2643875-A-G is Benign according to our data. Variant chr9-2643875-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 373721.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Likely_benign=2, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00224 (341/152296) while in subpopulation AFR AF= 0.00765 (318/41570). AF 95% confidence interval is 0.00696. There are 1 homozygotes in gnomad4. There are 154 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
VLDLRNM_003383.5 linkuse as main transcriptc.982A>G p.Ser328Gly missense_variant 7/19 ENST00000382100.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
VLDLRENST00000382100.8 linkuse as main transcriptc.982A>G p.Ser328Gly missense_variant 7/191 NM_003383.5 P98155-1

Frequencies

GnomAD3 genomes
AF:
0.00223
AC:
340
AN:
152178
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00765
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000772
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.000494
AC:
124
AN:
251092
Hom.:
0
AF XY:
0.000398
AC XY:
54
AN XY:
135700
show subpopulations
Gnomad AFR exome
AF:
0.00690
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000882
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.000218
AC:
318
AN:
1461888
Hom.:
2
Cov.:
31
AF XY:
0.000204
AC XY:
148
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.00753
Gnomad4 AMR exome
AF:
0.000380
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000117
Gnomad4 OTH exome
AF:
0.000497
GnomAD4 genome
AF:
0.00224
AC:
341
AN:
152296
Hom.:
1
Cov.:
32
AF XY:
0.00207
AC XY:
154
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.00765
Gnomad4 AMR
AF:
0.000785
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000773
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.000380
Hom.:
0
Bravo
AF:
0.00242
ESP6500AA
AF:
0.00635
AC:
28
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000634
AC:
77
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:2Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 17, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxDec 14, 2016A variant of uncertain significance has been identified in the VLDLR gene. The S328G variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The S328G variant is observed in 71/10,354 (0.7%) alleles from individuals of African background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The S328G variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoOct 29, 2015- -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 25, 2024- -
VLDLR-related disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesSep 01, 2021This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.082
T
BayesDel_noAF
Uncertain
0.11
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.36
T;.
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.019
T;T
MetaSVM
Uncertain
0.62
D
MutationAssessor
Uncertain
2.2
M;M
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.58
T
PROVEAN
Uncertain
-3.1
D;D
REVEL
Pathogenic
0.67
Sift
Benign
0.19
T;T
Sift4G
Benign
0.59
T;T
Polyphen
0.015
B;P
Vest4
0.72
MVP
0.83
MPC
0.10
ClinPred
0.078
T
GERP RS
5.2
Varity_R
0.21
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116306908; hg19: chr9-2643875; API